CMV

News

Pregnant woman puts her hands over her growing belly in shape of a heart

Moderna drops mRNA jab for CMV after phase 3 fail

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital CMV infections, once touted as a future blockbuster.

News

FDA clears Takeda drug for post-transplant CMV infections

Takeda has scored the first-ever FDA approval of a treatment for refractory cytomegalovirus (CMV) infections in organ transplant patients, which can lead to an increased risk of complicatio

News

FDA panel backs Takeda's CMV drug for transplant patients

Takeda is closing on a first FDA approval in the treatment of refractory cytomegalovirus (CMV) infections in organ transplant patients, after agency advisors voted unanimously in favour of

Moderna drops mRNA jab for CMV after phase 3 fail

FDA clears Takeda drug for post-transplant CMV infections

FDA panel backs Takeda's CMV drug for transplant patients

On AI and computational support of biochemistry, with Alan R...

The AI imperative: Establishing the standard for modern clin...

Editor's Picks